Hospital Virgen de la Victoria   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Malaga Spain (1989)

Organization Overview

First Clinical Trial
2007
NCT00543127
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital Virgen de la Victoria | Virgen de la Victoria Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aortic Valve Stenosis (Phase 4)

Asthma (Phase 4)

Breast Neoplasms (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Embolism (Phase 4)

Intracranial Embolism (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7